EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis

Ferrin Antony iD, Divya Kinha iD, Anna Nowińska, Barry T Rouse iD, Amol Suryawanshi iD

Clinical Microbiology Reviews · 12.09.2024 · 37 (3)

DOI: 10.1128/cmr.00006-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 12.09.2024. Verfasst von Ferrin Antony und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, California, USA. Hauptthemen laut MEDLINE: Keratitis, Herpetic, Herpesvirus 1, Human. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 378 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, HHS | NIH | National Eye Institute (NEI), NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human alphaherpesvirus 1 (HSV-1) is a highly successful neurotropic pathogen that primarily infects the epithelial cells lining the orofacial mucosa. After primary lytic replication in the oral, ocular, and nasal mucosal epithelial cells, HSV-1 establishes life-long latency in neurons within the trigeminal ganglion. Patients with compromised immune systems experience frequent reactivation of HSV-1 from latency, leading to virus entry in the sensory neurons, followed by anterograde transport and lytic replication at the innervated mucosal epithelial surface. Although recurrent infection of the corneal mucosal surface is rare, it can result in a chronic immuno-inflammatory condition called herpetic stromal keratitis (HSK). HSK leads to gradual vision loss and can cause permanent blindness in severe untreated cases. Currently, there is no cure or successful vaccine to prevent latent or recurrent HSV-1 infections, posing a significant clinical challenge to managing HSK and preventing vision loss. The conventional clinical management of HSK primarily relies on anti-virals to suppress HSV-1 replication, anti-inflammatory drugs (such as corticosteroids) to provide symptomatic relief from pain and inflammation, and surgical interventions in more severe cases to replace damaged cornea. However, each clinical treatment strategy has limitations, such as local and systemic drug toxicities and the emergence of anti-viral-resistant HSV-1 strains. In this review, we summarize the factors and immune cells involved in HSK pathogenesis and highlight alternate therapeutic strategies for successful clinical management of HSK. We also discuss the therapeutic potential of immunoregulatory cytokines and immunometabolism modulators as promising HSK therapies against emerging anti-viral-resistant HSV-1 strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Keratitis, HerpeticHerpesvirus 1, HumanHumansAntiviral AgentsAnimals

Stichwörter der Autor:innen

HSKHSV-1IFN-λISGsacyclovir-resistant HSV-1herpes keratitisimmunopathologyinterferonsneutrophils

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Molecular and Cell Biology, University of California, Berkeley, California, USA.
  • Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.
  • Ophthalmology Department, Railway Hospital in Katowice, Katowice, Poland.
  • College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.

ORCID-Profile: Ferrin Antony, Divya Kinha, Barry T Rouse, Amol Suryawanshi

Förderung

  • NEI NIH HHS
  • HHS | NIH | National Eye Institute (NEI)
  • NIAID NIH HHS

Zitieren

APA

Antony, F., Kinha, D., Nowińska, A., Rouse, B. T., & Suryawanshi, A. (2024). The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis. Clinical Microbiology Reviews, 37(3). https://doi.org/10.1128/cmr.00006-24

Vancouver

Antony F, Kinha D, Nowińska A, Rouse BT, Suryawanshi A. The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis. Clinical Microbiology Reviews. 2024;37(3). doi:10.1128/cmr.00006-24

BibTeX
@article{Antony2024,
  author = {Antony, Ferrin and Kinha, Divya and Nowińska, Anna and Rouse, Barry T and Suryawanshi, Amol},
  title = {The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis},
  journal = {Clinical Microbiology Reviews},
  year = {2024},
  volume = {37},
  number = {3},
  doi = {10.1128/cmr.00006-24}
}
Kostenlos starten →